| Resistant Hypertension in an Obese Patient With Obvious Obstructive Sleep Apnea and Occult Pheochromocytoma. | |
| | |
MedLine Citation:
|
PMID: 22281411 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
We report the case of a 34-year-old male patient who presented with generalized weakness, poorly controlled hypertension, nocturnal hypertension spikes, and morning headaches. The history of resistant hypertension, obesity, enlarged neck size, and loud irregular snoring strongly suggested obstructive sleep apnea (OSA). To exclude other possible causes of resistant hypertension, the patient underwent an abdominal ultrasound examination, which revealed a lesion in the left adrenal gland area. A pheochromocytoma was successfully removed via laparoscopic adrenalectomy, and both his hypertension and OSA responded dramatically. This case highlights the importance of excluding all causes of resistant hypertension regardless of the initial diagnosis. |
| | |
Authors:
|
Filip M Szymanski; Grzegorz Karpinski; Anna Hrynkiewicz-Szymanska; Krzysztof J Filipiak |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-24 |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: - ISSN: 1916-7075 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Cardiology, The Medical University of Warsaw, Warsaw, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prevalence, Awareness, Treatment, and Control of Hypertension Among Canadian Adults With Diabetes, 2...
Next Document: Inhibition of sPLA(2) and Endothelial Function: A Substudy of the SPIDER-PCI Trial.